Valuation of the CT LI-RADS treatment response V2018 in patients after first-line DEB-TACE for hepatocellular carcinoma (HCC)

In hepatocellular carcinoma (HCC), locoregional therapy (LRT) included transarterial chemotherapy embolization - TACE is performed as a bridging or downstaging treatment, improved overall survival, or a curative treatment.